4//SEC Filing
BERGER FRANKLIN M 4
Accession 0000950170-25-006489
CIK 0001593899other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 8:03 AM ET
Size
6.8 KB
Accession
0000950170-25-006489
Insider Transaction Report
Form 4
BERGER FRANKLIN M
Director
Transactions
- Purchase
Common Stock
2025-01-16$3.36/sh−10,000$33,614→ 476,897 total - Purchase
Common Stock
2025-01-15$3.19/sh−15,000$47,885→ 466,897 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.165 to $3.21. The Reporting Person undertakes to provide Atea Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.32 to $3.405. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Atea Pharmaceuticals, Inc.
CIK 0001593899
Entity typeother
Related Parties
1- filerCIK 0001273885
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 8:03 AM ET
- Size
- 6.8 KB